Access Bio: Access Bio Acquires Equity Stake in CuraPatients to Expand into U.S. Digital Healthcare Sector

Access Bio, a U.S.-based company focused on developing next-generation diagnostic kits, has secured a new equity stake in CuraPatients, a California-based digital population health-based company. The acquisition is aimed at accelerating Access Bio's entry into the digital healthcare sector in the United States. CuraPatients is known for its artificial intelligence-based software-as-a-service (SaaS) solution, which is [...]The post Access Bio Acquires Equity Stake in CuraPatients to Expand into U.S. Digital Healthcare Sector appeared first on CityLife.